Read in JCO:... - American Society of Clinical Oncology | Facebook
Met signaling pathway and EGF receptor tyrosine kinase inhibitor... | Download Scientific Diagram
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
new-molecular-drivers-in-nsclc-the-role-of-met
Targeting MET in Cancer: Obstacles and Potentials
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
Reciprocal relationship between MET amplification and T790M mutation.... | Download Scientific Diagram
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
The role of MET in chemotherapy resistance | Oncogene
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
IJMS | Free Full-Text | Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy | Journal of Medicinal Chemistry
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
Targeted Therapies Expanding for MET Dysregulation in NSCLC - ILCN.org (ILCN/WCLC)
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | SpringerLink
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | SpringerLink
MET Inhibition in Non-Small Cell Lung Cancer - European Medical Journal
EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.... | Download Scientific Diagram
Frontiers | I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer - Aguado - 2021 - Molecular Oncology - Wiley Online Library
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ on Twitter: "Great slides @ChristianRolfo on diagnostic challenges on MET amplification. #biomarker #lcsm #LungCancer https://t.co/zH1x2zrxYS" / Twitter
MET gene analysis by next-generation sequencing & fluorescence | Oncotarget
MET and TP 53: How They Relate to ALK Lung Cancer — ALK POSITIVE
